ekincare raises investment from MSD IDEA Studio Asia Pacific
ekincare has raised a total funding of $22M since 2015 till date
ekincare has raised a total funding of $22M since 2015 till date
The partnership provides Sai Life Sciences with a greenhouse gas emissions reduction of up to 90% for its international logistics needs by using SAF
DESTINY-Breast09 Phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2-positive metastatic patient population versus current 1st-line standard of care
Mistry is a seasoned finance professional having an extensive work experience spanning more than 25 years
Over 1500 stakeholders representing food businesses, packaging industries, recycling associations, regulatory bodies, environmental organizations, consumer groups, farmer groups, government departments participated in the consultation
Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets
Before joining Sun Pharma, Tulla served as Senior Vice President and Chief Commercial Head – Acute Cluster at Cipla
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Subscribe To Our Newsletter & Stay Updated